ABG
Ally Bridge Group Portfolio holdings
AUM
$114M
This Quarter Return
+6.6%
1 Year Return
+41.64%
3 Year Return
+246.39%
5 Year Return
–
10 Year Return
–
AUM
$117M
AUM Growth
+$117M
(-38%)
Cap. Flow
-$66.8M
Cap. Flow
% of AUM
-57.25%
Top 10 Holdings %
Top 10 Hldgs %
55.08%
Holding
38
New
9
Increased
1
Reduced
19
Closed
8
Top Buys
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$12.3M |
| 2 |
Axsome Therapeutics
AXSM
|
$5.64M |
| 3 |
Soleno Therapeutics
SLNO
|
$3.94M |
| 4 |
Korro Bio
KRRO
|
$2.69M |
| 5 |
EyePoint Pharmaceuticals
EYPT
|
$2.59M |
Top Sells
| 1 |
Sarepta Therapeutics
SRPT
|
$8.99M |
| 2 |
Tarsus Pharmaceuticals
TARS
|
$8.24M |
| 3 |
LBPH
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
|
$8.03M |
| 4 |
Revolution Medicines
RVMD
|
$7.41M |
| 5 |
SWTX
SpringWorks Therapeutics
SWTX
|
$6.25M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ITCI
1
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $12.3M | 10.58% | +147,750 | New | +$12.3M |
|
|
2
Tarsus Pharmaceuticals
TARS
$2.47B
| $9.59M | 8.22% | 173,144 -148,754 | -46% | -$8.24M |
|
3
Insmed
INSM
$28.8B
| $7.9M | 6.77% | 114,360 -36,473 | -24% | -$2.52M |
|
|
4
Axsome Therapeutics
AXSM
$6.05B
| $5.64M | 4.84% | +66,661 | New | +$5.64M |
|
5
Xenon Pharmaceuticals
XENE
$2.98B
| $5.07M | 4.35% | 129,291 -82,500 | -39% | -$3.23M |
|
6
CG Oncology
CGON
$2.04B
| $4.99M | 4.28% | 174,048 -89,218 | -34% | -$2.56M |
|
7
Merus
MRUS
$4.98B
| $4.91M | 4.21% | 116,796 -91,448 | -44% | -$3.85M |
|
|
BPMC
8
DELISTED
Blueprint Medicines
BPMC
| $4.87M | 4.18% | 55,892 -50,188 | -47% | -$4.38M |
|
9
Janux Therapeutics
JANX
$1.37B
| $4.83M | 4.14% | 90,292 -18,519 | -17% | -$992K |
|
|
CNTA
10
Centessa Pharmaceuticals
CNTA
$2.25B
| $4.1M | 3.51% | 244,538 -65,076 | -21% | -$1.09M |
|
|
11
Soleno Therapeutics
SLNO
$3.6B
| $3.94M | 3.38% | +87,629 | New | +$3.94M |
|
12
Geron
GERN
$893M
| $3.8M | 3.26% | 1,074,824 -256,229 | -19% | -$907K |
|
|
ALMS
13
Alumis Inc. Common Stock
ALMS
$479M
| $3.5M | 3% | 445,259 +26,843 | +6% | +$211K |
|
14
Praxis Precision Medicines
PRAX
$958M
| $3.46M | 2.97% | 44,982 -28,203 | -39% | -$2.17M |
|
15
Trevi Therapeutics
TRVI
$883M
| $3.22M | 2.76% | 781,489 -541,311 | -41% | -$2.23M |
|
16
Enliven Therapeutics
ELVN
$1.2B
| $3.19M | 2.73% | 141,710 -93,146 | -40% | -$2.1M |
|
|
17
Korro Bio
KRRO
$217M
| $2.69M | 2.31% | +70,678 | New | +$2.69M |
|
18
Jasper Therapeutics
JSPR
$45.5M
| $2.62M | 2.24% | 122,424 -277,042 | -69% | -$5.92M |
|
|
19
EyePoint Pharmaceuticals
EYPT
$797M
| $2.59M | 2.22% | +348,000 | New | +$2.59M |
|
|
WHWK
20
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$84.8M
| $2.58M | 2.21% | +817,939 | New | +$2.58M |
|
|
ATYR
21
aTyr Pharma
ATYR
$527M
| $2.53M | 2.17% | +699,730 | New | +$2.53M |
|
22
89bio
ETNB
$1.34B
| $2.49M | 2.13% | +317,833 | New | +$2.49M |
|
23
Tyra Biosciences
TYRA
$675M
| $2.43M | 2.09% | 175,063 -95,012 | -35% | -$1.32M |
|
24
Dianthus Therapeutics
DNTH
$759M
| $2.32M | 1.99% | +106,434 | New | +$2.32M |
|
25
MindMed
MNMD
$676M
| $2.3M | 1.97% | 330,275 -458,233 | -58% | -$3.19M |
|